Fingerprint
Dive into the research topics of 'Correction: Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors (RMD Open (2018) 4 (e000692)) DOI: 10.1136/rmdopen-2018-000692)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically